1.
J Enzyme Inhib Med Chem
; 26(5): 657-67, 2011 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21250818
RESUMO
A novel series of isoindolo[2,1-a]quinoxaline and indolo[1,2-a]quinoxaline derivatives was synthesized and evaluated in vitro against various human cancer cell lines for antiproliferative activity. These new compounds displayed activity against leukemia and breast cancer cell lines in the 3- to 18-µM concentration range.